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Comparison of ammoniated and nonammoniated extracts
in children with latex allergy
Hevea brasiliensis latex is used since decades to manu-
facture thousands of industrial and medical products,
particularly surgical gloves. However, immediate hyper-
sensitivity reactions to natural rubber latex began to be
reported starting from the 1970s, and they represent
nowadays a serious and increasingly health problem in
both adults and children (1, 2). Many individuals in the
general population can develop latex hypersensitivity
such as children playing with rubber toys, workers of the
rubber industry, people using household gloves. There are
also well-recognized subgroups at high risk, i.e. children
with spina biﬁda, patients undergoing frequent surgical
procedures and medical/paramedical personnel (3), prob-
ably due to the frequent/repeated contact with medical
devices. Recent evidence indicate that the mucosal
exposure to latex allergen is mainly due to aerodispersed
latex proteins, carried by particles of cornstarch powder,
used as lubricant in latex gloves (4). The typical symp-
toms of latex allergy include: urticaria, rhinitis, conjunc-
tivitis, asthma and, less frequently, anaphylactic shock
(5). In view of the possible severe manifestations, a
detailed diagnosis is mandatory for appropriate preven-
tion measures and therapeutic management.
Although it is generally accepted that the diagnosis of
allergy must be based on the clinical history of symptoms
associated to latex exposure, conﬁrmative skin prick test
(SPT) and/or serological assay are recommended (6).
Although the SPT test is generally considered the most
reliable tool, its accuracy and reproducibility can be
inﬂuenced by inadequate standardization (7). The diag-
nostic performance of SPT is highly dependent on the
protein extract and in particular on the raw material used
in its preparation. Glove eluates have been used in the
past for diagnosis, but their complex preparation proce-
dure and their considerable variability make diﬃcult the
production of commercial standardized preparations
(7, 8). The use of crude latex extracts, starting from
ammonium-treated latex (ammoniated latex, AL) or from
latex serum (nonammoniated latex, NAL) has been
proposed for the preparation of reference reagents, but
there is no general consensus on which is the most reliable
extract (9–11).
The aim of the present study was to compare SDS-
PAGE and immunoblotting proﬁles of AL and NAL
extracts using serum from children with well-ascertained
latex allergy.
Material and methods
Patients
Eighteen children (nine boys, nine girls, mean age 11.4 years, age
range 6–15 years) with ascertained immediate-type reactions to
latex were studied. They were selected from among patients
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attending the allergy units at the Departments of Paediatrics of the
Universities of Palermo and Milan. The following diagnostic cri-
teria for latex allergy were used:
• clinical history, showing correlation between symptoms and
latex exposure;
• positive SPT with a commercial AL extract (Lofarma S.p.a.,
Milan, Italy).
A detailed history for allergic symptoms and their causes was col-
lected in the group of children with latex allergy and past/actual
atopic disorders (asthma, rhinitis, atopic dermatitis) were recorded
in detail. No patient with spina biﬁda was included. All patients also
underwent a provocation test with latex glove. Serum samples were
collected at the ﬁrst visit and total serum IgE were determined by
the CAP-ﬂuorescence enzyme immunoassay FEIA system (Phar-
macia, Uppsala, Sweden). Speciﬁc IgE to latex were assayed by
CAP test (Pharmacia, Uppsala, Sweden). The study was approved
by the Ethic Committees of the Clinics and the parents signed a
written informed consent.
Skin test
Allergen skin tests were performed in duplicate on the forearm, with a
panel of commercial allergens (Lofarma S.p.A, Milan, Italy) inclu-
ding: dermatophagoides pteronyssinus, grass mix, parietaria judaica,
phleum pratense, artemisia, olive, dog and cat dander, Alternaria and
Cladosporium. Latex SPT was performed with a commercial prepar-
ation from an AL extract (Lofarma, Milan, Italy). A positive control
(10 mg/ml histamine hydrochloride) and a negative control (saline)
were also included. According to guidelines, skin wheal size (mean of
the major diameter plus its orthogonal) was measured after 15 min,
and 3 mm was considered the positivity cut-oﬀ (12).
Latex provocation test (glove test)
After washing their hands without drying, patients had to wear a
latex glove (Comﬁt NR Latex Powdered Gloves, PT WRP Buana
Multicorpora, Indonesia) on one hand and a vinyl glove (Allerderm
Laboratories, Petaluma, CA, USA) on the other hand. Clinical
reactions were evaluated by a physician at the onset of symptoms
and 30 min after taking oﬀ the glove. Finally, the hands were
washed again. The test response was evaluated as positive if
immediate reaction (urticaria, rhinoconjunctivitis, Quincke’s oede-
ma) occurred (13).
Preparation of ammoniated and nonammoniated extracts
Fresh latex of rubber tree (H. brasiliensis) mixed with ammonium
(0.7%) was provided by the Rubber Institute of Malaysia (Kuala
Lumpur, Malaysia). This ammoniated material was diluted (1 : 1,
v/v) with ammonium acetate buﬀer, pH 6.8, and vigorously stirred
for 30 min before centrifugation at 40 000 g at 4C for a further
30 min. The aqueous layer containing soluble protein, once care-
fully separated from the rubber particles, was ﬁltered through a
0.2-lm membrane and subsequently dialysed across a 5-kDa cut-oﬀ
membrane tube against 0.1 M ammonium carbonate and NaN3
0.03% as preservative. The protein content of this extract was
1.8 mg/ml as measured by the commercial BioRad Protein Assay
Dye Reagent (Bio-Rad, Milan, Italy) using BSA as reference
standard.
For the NAL, fresh latex from rubber trees was immediately
frozen without ammonization and stored at )80C. The soluble
proteins were then extracted by slowly thawing the frozen latex and
centrifuging it at 40 000 g for 30 min. The subsequent procedure
was identical to that described above. The protein content of this
extract (NAL) was 10.5 mg/ml.
SDS-PAGE and immunoblotting
Electrophoresis of AL and NAL extracts (30 ll containing 20 lg
of protein) was carried out in a 10% polyacrilamide precast
Nupage Bis-Tris gel according to manufacturer’s instructions
(Novex, Prodotti Gianni, Milan, Italy) at 180 mA for 1 h. The
resolved proteins were transferred onto a nitrocellulose membrane
(Protran BA 85, Schleicher and Schuell, Milan, Italy) according
to Towbin (14). The membrane was stained with 0.1% Coomassie
Brilliant Blue or saturated in Tris (0.025 M) buﬀered saline (TBS)
containing 5% defatted dry milk, before incubation with patient’s
sera and control sera from nonatopic subjects. Bound speciﬁc IgE
were detected by peroxydase-conjugated goat anti-human IgE
serum.
Results
Table 1 summarizes the characteristics of the allergic
children enrolled in the study. All patients had positive
clinical history, SPT and detectable latex-speciﬁc IgE,
ranging from 2.2 to 20.1 kU/l. Despite this, three out of
them had negative latex-glove test. These patients had
clearly positive latex skin test; one of them had asthma
and two urticaria upon latex exposure. Four children had
also a history of atopic dermatitis, but at the time of the
study they were in complete clinical remission. Concern-
ing clinical reactions to latex, rhinoconjunctivitis and
asthma were the most common symptoms (12/18 sub-
jects), followed by contact urticaria (11/18). Only four
patients reported a history of latex-related generalized
urticaria. This latter manifestation was strongly associ-
ated with the highest level of speciﬁc IgE (Table 1). There
was no signiﬁcant correlation between skin test positiv-
ity with the AL commercial extract and the concentra-
tion of speciﬁc IgE in serum (Spearman’s test, r ¼ 0.33,
P ¼ 0.17).
SDS-PAGE proﬁles of AL and NAL extracts are
shown in Fig. 1. NAL extract was resolved in many
bands with a molecular weight ranging from 5 to more
than 100 kDa (15). On the contrary, AL extract included
only a few components. All patients sera were tested in
immunoblotting using both NAL and AL extracts. IgE
reactivity against AL components was observed only in
ﬁve out of 18 patients (Fig. 2) and in all cases such
reactivity was homogeneously expressed against to
20-kDa band (likely corresponding to Hev b 6.01). The
immunoblotting proﬁle against NAL components was
more complex and a major number of sera (12 out 18)
resulted positive, as shown in Fig. 3. With NAL extract,
the IgE recognition pattern was heterogeneous and, in
addition to the 20-kDa band, a strong intensity in
correspondence of other components (likely Hev b 6.02,
Hev b 6.03 and Hev b 7) was observed.
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Discussion
There is an almost general consensus on the diagnosis of
latex allergy by SPT and/or RAST assay with latex
extracts, but there is still controversy on the most
appropriate raw material (ammoniated or nonammoni-
ated) for preparing extracts. Moreover, the real clinical
role of speciﬁc IgE-binding proteins present in natural
rubber latex is not still fully elucidated and sensitization
to diﬀerent groups of latex proteins seems to exist (9).
Latex juice harvested from H. brasiliensis plants contains
rubber particles and lutoids. They are suspended in an
Table 1. Characteristics of the latex-allergic children
Patient
number Sex Age
Clinical symptoms*
on exposure
Total
IgE (kU/l)
Latex CAP
(kU/l)
Latex SPT
wheal (mm) Glove test
1 M 9 CU, GU, RC 559 20.1 5 · 5 Positive
2 F 15 A, CU 640 18 7 · 5 Positive
3 M 14 CU, RC 292 4.7 6 · 6 Negative
4 M 14 A, CU, GU, RC 2500 18 20 · 10 Positive
5 F 15 A, CU, GU, RC 2440 11 5 · 4 Positive
6 M 6 CU 5007 5 6 · 5 Negative
7 F 15 A, CU, GU, RC 7400 20.1 8 · 5 Positive
8 F 10 A, RC 560 8.3 5 · 5 Positive
9 M 10 CU, RC 850 5.7 13 · 6 Positive
10 M 15 RC 918 2.9 5 · 5 Positive
11 M 13 A 182 4.7 5 · 4 Positive
12 F 10 CU 292 3.3 6 · 4 Positive
13 M 8 A 5600 2.3 7 · 7 Positive
14 F 8 A, RC 560 2.2 4 · 4 Negative
15 F 10 A, RC 890 2.9 11 · 5 Positive
16 M 9 A, CU, RC 911 8.5 7 · 5 Positive
17 F 14 A, CU 6490 11.1 8 · 5 Positive
18 F 11 A, RC 850 2.5 6 · 4 Positive
* A, asthma; CU, contact urticaria; GU, generalized urticaria; RC, rhinoconjunctivitis.
Hev b 4
Hev b 7 (patatin-like protein)
Hev b 2 (β-glucanase)
Hev b 11(chitinase)
Hev b 3 / Hev b 10
Hev b 6.01 (Prohevein)
Hev b 6.03 (Prohevein
C-domain) / Hev b 1 (REF)
Hev b 6.02 (Hevein)
m.w.
kDa
NAL AL
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Figure 1. SDS-PAGE proﬁle of NAL and AL extracts.
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Figure 2. IgE reactivity pattern of sera from latex-sensitive
patients against AL components by immunoblotting. N: pool of
sera from nonallergic subject.
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aqueous liquid called C-serum, which contains Hev b 1, 3,
5, 7, 8 and 9. The lutoids contain another aqueous ﬂuid,
called B-serum, which can be easily released after
breaking them by freezing and thawing. B-serum includes
other allergens such as Hev b 2, Hev b 4 and Hev b 6, and
a small quantity of Hev b 1 and 3 (16). The extract used in
this study, called NAL, derives from a raw material
constituted by B- and C-sera. In the case of AL, the fresh
lymph of rubber tree is treated with ammonium, which is
immediately added after harvesting.
We compared AL and NAL extracts in immunoblot-
ting experiments, using sera from children with latex
allergy. Noticeably, three children had a negative glove
test despite their clear clinical allergy. This can depend in
part on the glove used, since it is well known that the
allergenic content is largely variable among diﬀerent
manufacturers (17).
Our immunoblotting data showed diﬀerent results,
depending on the raw material used in the preparation of
the extract. This observation can have relevant diagnostic
implications because the use of AL extract instead of
NAL may produce false negative results (18). The
relatively low IgE-binding capacity of AL extract may
be due to the chemical action of ammonium. It is likely
that the addition of ammonium alters somewhere the
structure of latex components or destroys them or
modiﬁes relevant IgE-relevant epitopes. Moreover, Hev
b 6.02, which is 5 kDa, may be partially lost in the
dialysis procedure. The immunoblotting proﬁle of AL in
our allergic children showed a low IgE binding capacity,
and virtually all serum IgE bound a 20-kDa protein
(likely Hev b 6.01), whereas the NAL extract detected IgE
binding to other components, which might be Hev b 1,
prohevein and Hev b 7. It is likely that the immunoblot-
ting proﬁle against NAL components may better reﬂect
the content of proteins responsible for the type I reactions
(19). In fact, allergic patients may react to minor or
major protein determinants with diﬀerent molecular
weights. For instance, in the past, Hev b 7 was not
considered an important allergen (20), but recently its
relevance in children has been outlined (21). Indeed, the
sera from six children with ascertained latex allergy (and
positive provocation test) did not react against the
proteins of AL and NAL extracts, suggesting that other
IgE-determinants, not resolved by blotting, should exist.
Data on SDS-PAGE proﬁle and immunoblotting of
AL and NAL extracts suggest that NAL extract maybe
more appropriate, at least in research setting, since it can
identify sensitizations to a larger number of components
of latex, although it has been shown that, in vivo, the
eﬃciency of NAL is even inferior to a low-ammonium
extract (22). In conclusion, our results support the
diagnostic value of NAL extract as in vitro assay in the
diagnosis of latex allergy in atopic children.
1 2 3
3
6
11
17
19
31
52
98
kDa
m.w. 4 5 6 7 8 9 10 11 12 N
Figure 3. IgE reactivity pattern of sera from latex-sensitive patients against NAL components by immunoblotting. N: pool of sera
from nonallergic subject.
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